These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25854364)

  • 1. Integrative meta-analysis of multiple gene expression profiles in acquired gemcitabine-resistant cancer cell lines to identify novel therapeutic biomarkers.
    Lee YS; Kim JK; Ryu SW; Bae SJ; Kwon K; Noh YH; Kim SY
    Asian Pac J Cancer Prev; 2015; 16(7):2793-800. PubMed ID: 25854364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
    Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles.
    Chen Z; Zhao L; Shi K; Chen B
    Clin Lab; 2018 May; 64(5):749-757. PubMed ID: 29739052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH; Zhang ZY; Che CL; Mei YF; Shi YZ
    Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP
    J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis.
    Nakai Y; Otsuka M; Hoshida Y; Tada M; Komatsu Y; Kawabe T; Omata M
    Oncol Rep; 2005 Nov; 14(5):1263-7. PubMed ID: 16211294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
    Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
    Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.
    Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR
    Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.
    Ina S; Hirono S; Noda T; Yamaue H
    Pancreas; 2010 May; 39(4):473-85. PubMed ID: 19959962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis.
    Kim D; Lee YS; Kim JK; Kim SY
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):581-597. PubMed ID: 32422012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
    Yang ZQ; Liu YJ; Zhou XL
    Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
    Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].
    Dong M; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Zha YY; Lu HY; Wu M
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):323-8. PubMed ID: 15059518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.
    Hernández-Vargas H; Rodríguez-Pinilla SM; Julián-Tendero M; Sánchez-Rovira P; Cuevas C; Antón A; Ríos MJ; Palacios J; Moreno-Bueno G
    Breast Cancer Res Treat; 2007 Apr; 102(2):157-72. PubMed ID: 17039268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.